Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016, Article ID 7945953, 4 pages
http://dx.doi.org/10.1155/2016/7945953
Case Report

Autoimmune Lymphoproliferative Syndrome: A Rare Cause of Disappearing HDL Syndrome

1Division of Pediatric Endocrinology, Mayo Clinic, Rochester, MN 55902, USA
2Division of Pediatric Allergy and Immunology, Mayo Clinic, Rochester, MN 55902, USA
3Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN 55902, USA

Received 11 April 2016; Revised 8 July 2016; Accepted 12 July 2016

Academic Editor: Takahisa Gono

Copyright © 2016 Swetha Sriram et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. K. Kit, M. D. Carroll, D. A. Lacher, P. D. Sorlie, J. M. DeJesus, and C. L. Ogden, “Trends in serum lipids among US youths aged 6 to 19 years, 1988–2010,” The Journal of the American Medical Association, vol. 308, no. 6, pp. 591–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. K. Kit, E. Kuklina, M. D. Carroll, Y. Ostchega, D. S. Freedman, and C. L. Ogden, “Prevalence of and trends in dyslipidemia and blood pressure among us children and adolescents, 1999–2012,” JAMA Pediatrics, vol. 169, no. 3, pp. 272–279, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Goldberg and D. Rader, “The disappearing high density lipoprotein syndrome,” Journal of Clinical Lipidology, vol. 9, no. 1, pp. 91–92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. C. S. Alvarado, S. E. Straus, S. Li et al., “Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children—report on diagnosis and management of five patients,” Pediatric Blood and Cancer, vol. 43, no. 2, pp. 164–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. Moraitis, L. A. Freeman, R. D. Shamburek et al., “Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency,” Journal of Clinical Lipidology, vol. 9, no. 1, pp. 81–90, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Rader and E. M. deGoma, “Approach to the patient with extremely low HDL-cholesterol,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 10, pp. 3399–3407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. B. Park, S. K. Lee, W. K. Lee et al., “Lipid profiles in untreated patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 26, no. 8, pp. 1701–1704, 1999. View at Google Scholar · View at Scopus
  8. R. B. Goldberg and A. J. Mendez, “Severe acquired (secondary) high-density lipoprotein deficiency,” Journal of Clinical Lipidology, vol. 1, no. 1, pp. 41–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Musunuru, J. P. Pirruccello, R. Do et al., “Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia,” The New England Journal of Medicine, vol. 363, no. 23, pp. 2220–2227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. E. Marik, “Dyslipidemia in the critically ill,” Critical Care Clinics, vol. 22, no. 1, pp. 151–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tomiki, S. Suda, M. Tanaka et al., “Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer. A case control study,” Journal of Experimental and Clinical Cancer Research, vol. 23, no. 2, pp. 233–240, 2004. View at Google Scholar · View at Scopus
  12. J. M. Petit, M. Benichou, L. Duvillard et al., “Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis,” The American Journal of Gastroenterology, vol. 98, no. 5, pp. 1150–1154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. I. J. Fuss, W. Strober, J. K. Dale et al., “Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity,” Journal of Immunology, vol. 158, no. 4, pp. 1912–1918, 1997. View at Google Scholar · View at Scopus
  14. U. Lopatin, X. Yao, R. K. Williams et al., “Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression,” Blood, vol. 97, no. 10, pp. 3161–3170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. J. H. Bleesing, “Autoimmune lymphoproliferative syndrome (ALPS),” Current Pharmaceutical Design, vol. 9, no. 3, pp. 265–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. I. B. McInnes, G. C. Illei, C. L. Danning et al., “IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis,” Journal of Immunology, vol. 167, no. 7, pp. 4075–4082, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Wolk, E. Witte, U. Reineke et al., “Is there an interaction between interleukin-10 and interleukin-22?” Genes & Immunity, vol. 6, no. 1, pp. 8–18, 2005. View at Publisher · View at Google Scholar · View at Scopus